{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:14:45Z","timestamp":1788315285766,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,18]]},"DOI":"10.7759\/cureus.45485","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:27:10Z","timestamp":1695047230000},"source":"Crossref","is-referenced-by-count":10,"title":["Opioid Prescription in Patients With Chronic Kidney Disease: A Systematic Review of Comparing Safety and Efficacy of Opioid Use in Chronic Kidney Disease Patients"],"prefix":"10.7759","author":[{"given":"Victor A","family":"Odoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakanksha","family":"Pitliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa","family":"AlEdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Japneet","family":"Bhangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhleen Kaur","family":"Manshahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzair","family":"Chatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5603\/PMPI.2022.0010","article-title":"Use of opioid analgesics in chronic kidney disease","volume":"16","author":"So\u0142tysik A","year":"2022","unstructured":"So\u0142tysik A, Graczyk M, & Woro\u0144 J. Use of opioid analgesics in chronic kidney disease. Palliative Med. 2022, 16:156-66. 10.5603\/PMPI.2022.0010","journal-title":"Palliative Med"},{"key":"ref2","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin R","year":"2008","unstructured":"Benyamin R, Trescot AM, Datta S, et al.. Opioid complications and side effects. Pain Physician. 2008, 11:S105-20.","journal-title":"Pain Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09801.x","article-title":"Chronic renal diseases as a public health problem: epidemiology, social, and economic implications","author":"Schieppati A","year":"2005","unstructured":"Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl. 2005, S7-S10. 10.1111\/j.1523-1755.2005.09801.x","journal-title":"Kidney Int Suppl"},{"key":"ref4","article-title":"The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice","volume":"21","author":"Murtagh FE","year":"2007","unstructured":"Murtagh FE, Chai MO, Donohoe P, Edmonds PM, Higginson IJ. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother. 2007, 21:5-16.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.08.018","article-title":"Opioid management in CKD","volume":"77","author":"Lu E","year":"2021","unstructured":"Lu E, Schell JO, Koncicki HM. Opioid management in CKD. Am J Kidney Dis. 2021, 77:786-95. 10.1053\/j.ajkd.2020.08.018","journal-title":"Am J Kidney Dis"},{"key":"ref6","article-title":"Opioid analgesics in patients with chronic renal failure: principles for use and current guidelines (Article in Italian)","volume":"28","author":"Niscola P","year":"2011","unstructured":"Niscola P, Giovannini M, Vischini G, et al.. Opioid analgesics in patients with chronic renal failure: principles for use and current guidelines (Article in Italian). G Ital Nefrol. 2011, 28:269-77.","journal-title":"G Ital Nefrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.126185","article-title":"Severe chronic renal failure in association with oxycodone addiction: a new form of fibrillary glomerulopathy","volume":"33","author":"Hill P","year":"2002","unstructured":"Hill P, Dwyer K, Kay T, Murphy B. Severe chronic renal failure in association with oxycodone addiction: a new form of fibrillary glomerulopathy. Hum Pathol. 2002, 33:783-7. 10.1053\/hupa.2002.126185","journal-title":"Hum Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S262843","article-title":"Safe use of opioids in chronic kidney disease and hemodialysis patients: tips and tricks for non-pain specialists","volume":"16","author":"Coluzzi F","year":"2020","unstructured":"Coluzzi F, Caputi FF, Billeci D, Pastore AL, Candeletti S, Rocco M, Romualdi P. Safe use of opioids in chronic kidney disease and hemodialysis patients: tips and tricks for non-pain specialists. Ther Clin Risk Manag. 2020, 16:821-37. 10.2147\/TCRM.S262843","journal-title":"Ther Clin Risk Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311406313","article-title":"A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project","volume":"25","author":"King S","year":"2011","unstructured":"King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011, 25:525-52. 10.1177\/0269216311406313","journal-title":"Palliat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3447-0","article-title":"The use of opioids in cancer patients with renal impairment-a systematic review","volume":"25","author":"Sande TA","year":"2017","unstructured":"Sande TA, Laird BJ, Fallon MT. The use of opioids in cancer patients with renal impairment-a systematic review. Support Care Cancer. 2017, 25:661-75. 10.1007\/s00520-016-3447-0","journal-title":"Support Care Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00600115","article-title":"Pain, analgesics, and safety in patients with CKD","volume":"10","author":"Davison SN","year":"2015","unstructured":"Davison SN. Pain, analgesics, and safety in patients with CKD. Clin J Am Soc Nephrol. 2015, 10:350-2. 10.2215\/CJN.00600115","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06520714","article-title":"Chronic pain and analgesic use in CKD: implications for patient safety","volume":"10","author":"Wu J","year":"2015","unstructured":"Wu J, Ginsberg JS, Zhan M, Diamantidis CJ, Chen J, Woods C, Fink JC. Chronic pain and analgesic use in CKD: implications for patient safety. Clin J Am Soc Nephrol. 2015, 10:435-42. 10.2215\/CJN.06520714","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients","volume":"28","author":"Dean M","year":"2004","unstructured":"Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004, 28:497-504. 10.1016\/j.jpainsymman.2004.02.021","journal-title":"J Pain Symptom Manage"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/138945010791170879","article-title":"The use of major analgesics in patients with renal dysfunction","volume":"11","author":"Niscola P","year":"2010","unstructured":"Niscola P, Scaramucci L, Vischini G, et al.. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010, 11:752-8. 10.2174\/138945010791170879","journal-title":"Curr Drug Targets"},{"key":"ref15","article-title":"The principles of management of pain exacerbations in cancer patients (Article in Polish)","volume":"8","author":"Dzier\u017canowski T","year":"2016","unstructured":"Dzier\u017canowski T, Cia\u0142kowska-Rysz A. The principles of management of pain exacerbations in cancer patients (Article in Polish). Pall Med. 2016, 8:1-8.","journal-title":"Pall Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref17","article-title":"Medical Genetics Summaries","author":"National Center for Biotechnology Information","year":"2012","unstructured":"National Center for Biotechnology Information. Medical Genetics Summaries. Pratt VM, Scott SA, Pirmohamed M, et al. (ed): National Center for Biotechnology Information (US), Bethesda, MD; 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK61999\/."},{"key":"ref18","article-title":"SIAARTI recommendations for chronic noncancer pain","volume":"72","author":"Ambrosio F","year":"2006","unstructured":"Ambrosio F, Finco G, Mattia C, et al.. SIAARTI recommendations for chronic noncancer pain. Minerva Anestesiol. 2006, 72:859-80.","journal-title":"Minerva Anestesiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12812","article-title":"Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions","volume":"44","author":"Raffa RB","year":"2019","unstructured":"Raffa RB, Taylor R Jr, Pergolizzi JV Jr. Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions. J Clin Pharm Ther. 2019, 44:361-71. 10.1111\/jcpt.12812","journal-title":"J Clin Pharm Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder G","year":"2018","unstructured":"Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci. 2018, 41:453-73. 10.1146\/annurev-neuro-080317-061522","journal-title":"Annu Rev Neurosci"},{"key":"ref21","article-title":"The metabolism and excretion of buprenorphine in humans","volume":"12","author":"Cone EJ","year":"1984","unstructured":"Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE. The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos. 1984, 12:577-81.","journal-title":"Drug Metab Dispos"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/64.3.276","article-title":"Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites","volume":"64","author":"Hand CW","year":"1990","unstructured":"Hand CW, Sear JW, Uppington J, Ball MJ, McQuay HJ, Moore RA. Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites. Br J Anaesth. 1990, 64:276-82. 10.1093\/bja\/64.3.276","journal-title":"Br J Anaesth"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp150748","article-title":"Safety of chronic transdermal fentanyl use in patients receiving hemodialysis","volume":"73","author":"Han J","year":"2016","unstructured":"Han J, Saraf SL, Gordeuk VR, Gowhari M. Safety of chronic transdermal fentanyl use in patients receiving hemodialysis. Am J Health Syst Pharm. 2016, 73:947-8. 10.2146\/ajhp150748","journal-title":"Am J Health Syst Pharm"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1002\/j.1875-9114.1997.tb03750.x","article-title":"Fentanyl pharmacokinetics in patients undergoing renal transplantation","volume":"17","author":"Koehntop DE","year":"1997","unstructured":"Koehntop DE, Rodman JH. Fentanyl pharmacokinetics in patients undergoing renal transplantation. Pharmacotherapy. 1997, 17:746-52.","journal-title":"Pharmacotherapy"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1982.tb04194.x","article-title":"Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure","volume":"34","author":"Bower S","year":"1982","unstructured":"Bower S. Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure. J Pharm Pharmacol. 1982, 34:102-6. 10.1111\/j.2042-7158.1982.tb04194.x","journal-title":"J Pharm Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631060-00002","article-title":"Pharmacokinetics of opioids in renal dysfunction","volume":"31","author":"Davies G","year":"1996","unstructured":"Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet. 1996, 31:410-22. 10.2165\/00003088-199631060-00002","journal-title":"Clin Pharmacokinet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(80)90180-5","article-title":"Methadone use in patients with chronic renal disease","volume":"5","author":"Kreek MJ","year":"1980","unstructured":"Kreek MJ, Schecter AJ, Gutjahr CL, Hecht M. Methadone use in patients with chronic renal disease. Drug Alcohol Depend. 1980, 5:197-205. 10.1016\/0376-8716(80)90180-5","journal-title":"Drug Alcohol Depend"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1177\/082585979300900110","article-title":"Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone","volume":"9","author":"Fainsinger R","year":"1993","unstructured":"Fainsinger R, Schoeller T, Boiskin M, Bruera E. Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone. J Palliat Care. 1993, 9:53-5.","journal-title":"J Palliat Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)00121-Z","article-title":"Hydromorphone metabolite accumulation in renal failure","volume":"10","author":"Babul N","year":"1995","unstructured":"Babul N, Darke A C, Hagen N. Hydromorphone metabolite accumulation in renal failure. J Pain Symptom Manage. 1995, 10:184-6. 10.1016\/0885-3924(94)00121-Z","journal-title":"J Pain Symptom Manage"},{"key":"ref30","article-title":"Narcotic analgesics in renal failure","volume":"55","author":"Fitzgerald J","year":"1991","unstructured":"Fitzgerald J. Narcotic analgesics in renal failure. Conn Med. 1991, 55:701-4.","journal-title":"Conn Med"},{"key":"ref31","article-title":"Miller's Anesthesia","year":"2010","unstructured":"Miller's Anesthesia. Eriksson LI (ed). Churchill Livingstone, Philadelphia, PA; 2010."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.01.010","article-title":"Oxycodone","volume":"29","author":"Kalso E","year":"2005","unstructured":"Kalso E. Oxycodone. J Pain Symptom Manage. 2005, 29:S47-56. 10.1016\/j.jpainsymman.2005.01.010","journal-title":"J Pain Symptom Manage"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/0952-8180(95)00092-5","article-title":"The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation","volume":"8","author":"Kirvela M","year":"1996","unstructured":"Kirvela M, Lindgren L, Seppala T, Olkkola KT. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation. J Clin Anesth. 1996, 8:13-8. 10.1016\/0952-8180(95)00092-5","journal-title":"J Clin Anesth"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-005-0843-2","article-title":"No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients","volume":"14","author":"Riley J","year":"2006","unstructured":"Riley J, Ross JR, Rutter D, Wells AU, Goller K, du Bois R, Welsh K. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer. 2006, 14:56-64. 10.1007\/s00520-005-0843-2","journal-title":"Support Care Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.2-28.v3","article-title":"Management of acute and post-operative pain in chronic kidney disease","volume":"2","author":"Parmar MS","year":"2013","unstructured":"Parmar MS, Parmar KS. Management of acute and post-operative pain in chronic kidney disease. F1000Res. 2013, 2:28. 10.12688\/f1000research.2-28.v3","journal-title":"F1000Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346020-00008","article-title":"Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states","volume":"46","author":"Lee CR","year":"1993","unstructured":"Lee CR, McTavish D, Sorkin EM. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs. 1993, 46:313-40. 10.2165\/00003495-199346020-00008","journal-title":"Drugs"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(96)00138-6","article-title":"Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl","volume":"101","author":"Gibson TP","year":"1996","unstructured":"Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Am J Med. 1996, 101:47S-53S. 10.1016\/s0002-9343(96)00138-6","journal-title":"Am J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.suponc.2012.05.002","article-title":"Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","volume":"10","author":"Davis MP","year":"2012","unstructured":"Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012, 10:209-19. 10.1016\/j.suponc.2012.05.002","journal-title":"J Support Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199802000-00049","article-title":"Nondialyzability of fentanyl with high-efficiency and high-flux membranes","volume":"86","author":"Joh J","year":"1998","unstructured":"Joh J, Sila MK, Bastani B. Nondialyzability of fentanyl with high-efficiency and high-flux membranes. Anesth Analg. 1998, 86:447. 10.1097\/00000539-199802000-00049","journal-title":"Anesth Analg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181b1c99f","article-title":"2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group","volume":"34","author":"Furlan AD","year":"2009","unstructured":"Furlan AD, Pennick V, Bombardier C, van Tulder M. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976). 2009, 34:1929-41. 10.1097\/BRS.0b013e3181b1c99f","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00204.x","article-title":"Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)","volume":"8","author":"Pergolizzi J","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, et al.. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008, 8:287-313. 10.1111\/j.1533-2500.2008.00204.x","journal-title":"Pain Pract"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/01.pap.0000249926.89087.d8","article-title":"Use of hydromorphone (Dilaudid) and morphine for patients with hepatic and renal impairment","volume":"14","author":"Razaq M","year":"2007","unstructured":"Razaq M, Balicas M, Mankan N. Use of hydromorphone (Dilaudid) and morphine for patients with hepatic and renal impairment. Am J Ther. 2007, 14:414-6. 10.1097\/01.pap.0000249926.89087.d8","journal-title":"Am J Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10636","article-title":"Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion","volume":"95","author":"Mercadante S","year":"2002","unstructured":"Mercadante S, Villari P, Ferrera P, Casuccio A, Fulfaro F. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer. 2002, 95:203-8. 10.1002\/cncr.10636","journal-title":"Cancer"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/01.smj.0000242876.45747.0a","article-title":"Oxycodone accumulation in a hemodialysis patient","volume":"100","author":"Foral PA","year":"2007","unstructured":"Foral PA, Ineck JR, Nystrom KK. Oxycodone accumulation in a hemodialysis patient. South Med J. 2007, 100:212-4. 10.1097\/01.smj.0000242876.45747.0a","journal-title":"South Med J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.19.1423.34854","article-title":"Tramadol and seizures: a surveillance study in a managed care population","volume":"20","author":"Gardner JS","year":"2000","unstructured":"Gardner JS, Blough D, Drinkard CR, Shatin D, Anderson G, Graham D, Alderfer R. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy. 2000, 20:1423-31. 10.1592\/phco.20.19.1423.34854","journal-title":"Pharmacotherapy"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.12","article-title":"Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease","volume":"43","author":"Guay DR","year":"1988","unstructured":"Guay DR, Awni WM, Findlay JW, et al.. Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease. Clin Pharmacol Ther. 1988, 43:63-71. 10.1038\/clpt.1988.12","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/168240-opioid-prescription-in-patients-with-chronic-kidney-disease-a-systematic-review-of-comparing-safety-and-efficacy-of-opioid-use-in-chronic-kidney-disease-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:05:26Z","timestamp":1707491126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/168240-opioid-prescription-in-patients-with-chronic-kidney-disease-a-systematic-review-of-comparing-safety-and-efficacy-of-opioid-use-in-chronic-kidney-disease-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.45485","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}